A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease

by Karpecki P, Wirta D, Osmanovic S, Dhamdhere K
Published 2020-12-01

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

by Shen Lee B, Kabat AG, Bacharach J, Karpecki P, Luchs J
Published 2020-01-01

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease

by McMullin D, Clark D, Cavanagh B, Karpecki P, Brady TC
Published 2021-09-01

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

by Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P
Published 2021-01-01

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye

by Torkildsen G, Brujic M, Cooper MS, Karpecki P, Majmudar P, Trattler W, Reis M, Ciolino JB
Published 2017-10-01